dalteparin has been researched along with Demyelinative Myelitis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The evidence for outpatient pulmonary embolism (PE) management apart from hospitalization is expanding." | 1.56 | Primary care physicians comprehensively manage acute pulmonary embolism without higher-level-of-care transfer: A report of two cases. ( Hofmann, ER; Isaacs, DJ; Johnson, EJ; Rangarajan, S; Vinson, DR, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isaacs, DJ | 1 |
| Johnson, EJ | 1 |
| Hofmann, ER | 1 |
| Rangarajan, S | 1 |
| Vinson, DR | 1 |
1 other study available for dalteparin and Demyelinative Myelitis
| Article | Year |
|---|---|
Primary care physicians comprehensively manage acute pulmonary embolism without higher-level-of-care transfer: A report of two cases.
Topics: Acute Disease; Adult; Ambulatory Care; Anticoagulants; Antithrombins; Chest Pain; Computed Tomograph | 2020 |